Sign in

CIK 0001396814

  • Large accelerated filer

Pacira BioSciences, Inc.

Sign in to watch
Ticker
PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
510619477
Phone
+1 650-242-8052
Business address
2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
Former names
Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$217,920
in 1 filing, $218K under 10b5-1 plans

Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. RIKER LAUREN −$218K Senior Vice President, Finance sold 9% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Teehan Brendan Chief Commercial Officer Returned to the company −100,934.27 $36.50 $3.7M 0
2026-11-17 Teehan Brendan Chief Commercial Officer Returned to the company · Stock Option (Right to Buy) −99,500 0
2026-02-11 Teehan Brendan Chief Commercial Officer Grant or award +51,714 100,934.27
2026-01-30 Teehan Brendan Chief Commercial Officer Shares withheld for taxes −5,182 $20.54 $106K 49,220.27
2025-12-31 Teehan Brendan Chief Commercial Officer Grant or award +402.27 $10.76 $4K 54,402.27
2025-02-04 Teehan Brendan Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +99,500 $26.59 $2.6M 99,500
2025-02-01 Teehan Brendan Chief Commercial Officer Grant or award +54,000 54,000

Page 1 of 1 · 7 trades